| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2894039 | Atherosclerosis | 2008 | 8 Pages |
Abstract
Treatment with rosuvastatin improved basal NOS activity in the renal circulation of hypercholesterolemic patients, suggestive of a nephroprotective effect. In view of the close relation between altered renal function and cardiovascular events, these nephroprotective effects may contribute to the improved CV prognosis associated with statin treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christian Ott, Markus P. Schlaich, Bernhard M.W. Schmidt, Stephanie I. Titze, Tim Schäufele, Roland E. Schmieder,